Synergic Interactions Between Hepatic Stellate Cells and Uveal Melanoma in Metastatic Growth.

fibrogenesis hepatic stellate cells histopathological growth patterns metastatic uveal melanoma quantitative polarization microscopy xenografts

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Jul 2019
Historique:
received: 26 06 2019
revised: 19 07 2019
accepted: 22 07 2019
entrez: 27 7 2019
pubmed: 28 7 2019
medline: 28 7 2019
Statut: epublish

Résumé

Uveal melanoma (UM) is a malignant intraocular tumor that spreads to the liver in half of the cases. Since hepatic cells could play a role in the therapeutic resistance of metastatic UM, the purpose of our study was to investigate the pro-invasive role of hepatic stellate cells (HSteCs) in metastatic UM at the micro- and macro-metastatic stages. We first performed an immunostaining with the alpha-smooth muscle actin (αSMA) to localize activated HSteCs in UM liver macro-metastases from four patients. Their accumulation of collagen was assessed with Masson's Trichrome stain. Next, we inoculated metastatic UM cells alone or with human HSteCs in triple-immunodeficient mice, in order to determine if HSteCs are recruited as early as the micro-metastatic stage. The growth of metastatic foci was imaged in the liver by

Identifiants

pubmed: 31344830
pii: cancers11081043
doi: 10.3390/cancers11081043
pmc: PMC6721369
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Fonds de Recherche du Québec - Santé
ID : NA
Organisme : Canada Foundation for Innovation
ID : 32808
Organisme : Fondation du CHU de Québec
ID : NA
Organisme : Fondation des Maladies de l'Oeil
ID : NA
Organisme : Vision Health Research Network
ID : NA
Organisme : Cancer Research Society
ID : NA

Références

Ophthalmology. 1999 Aug;106(8):1579-87
pubmed: 10442907
Lab Invest. 2002 Mar;82(3):323-33
pubmed: 11896211
Nat Rev Cancer. 2004 Oct;4(10):806-13
pubmed: 15510161
Melanoma Res. 2005 Aug;15(4):257-66
pubmed: 16034303
Arch Ophthalmol. 2005 Dec;123(12):1639-43
pubmed: 16344433
Mol Vis. 2005 Dec 14;11:1101-11
pubmed: 16379022
Future Oncol. 2008 Oct;4(5):629-36
pubmed: 18922120
Nat Rev Mol Cell Biol. 2009 Jan;10(1):63-73
pubmed: 19197333
Am J Ophthalmol. 2009 Jul;148(1):119-27
pubmed: 19375060
Oncogene. 2011 Sep 1;30(35):3766-83
pubmed: 21478904
Hepatology. 2011 Aug;54(2):707-13
pubmed: 21520207
Curr Probl Cancer. 2011 Jul-Aug;35(4):211-24
pubmed: 21911184
Pigment Cell Melanoma Res. 2012 Mar;25(2):171-81
pubmed: 22268848
JAMA Ophthalmol. 2013 Apr;131(4):462-9
pubmed: 23392528
PLoS Curr. 2013 Apr 09;5:null
pubmed: 23591547
J Clin Invest. 2013 May;123(5):1902-10
pubmed: 23635788
Clin Exp Metastasis. 2013 Dec;30(8):969-76
pubmed: 23793989
Pigment Cell Melanoma Res. 2014 Mar;27(2):297-308
pubmed: 24354797
Science. 2014 May 9;344(6184):641-5
pubmed: 24812403
EMBO Rep. 2014 Dec;15(12):1243-53
pubmed: 25381661
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
Integr Biol (Camb). 2015 Oct;7(10):1120-34
pubmed: 25959051
Trends Cell Biol. 2016 Jul;26(7):486-497
pubmed: 27056543
JAMA Ophthalmol. 2016 Jul 1;134(7):728-33
pubmed: 27123562
Br J Cancer. 2016 Jun 28;115(1):34-9
pubmed: 27280634
Oncotarget. 2016 Aug 2;7(31):49623-49635
pubmed: 27391064
Gastroenterology. 2016 Nov;151(5):1011-1024.e7
pubmed: 27506299
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5288-5301
pubmed: 27723895
Eye (Lond). 2017 Feb;31(2):241-257
pubmed: 27911450
Mol Cancer Ther. 2017 Mar;16(3):516-528
pubmed: 28138035
Lancet Oncol. 2017 Jun;18(6):792-802
pubmed: 28395880
Curr Oncol Rep. 2017 Jul;19(7):45
pubmed: 28508938
Cancer Treat Rev. 2017 Nov;60:44-52
pubmed: 28881222
Oncotarget. 2016 Oct 12;8(32):52281-52293
pubmed: 28881729
Br J Cancer. 2017 Nov 7;117(10):1427-1441
pubmed: 28982110
J Gastroenterol. 2018 Jan;53(1):6-17
pubmed: 29094206
Sci Transl Med. 2018 Jan 3;10(422):
pubmed: 29298864
Nat Commun. 2018 Jan 9;9(1):116
pubmed: 29317634
J Biomech Eng. 2018 Jul 1;140(7):
pubmed: 29560498
Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672
pubmed: 29738114
J Pathol Clin Res. 2018 Oct;4(4):227-240
pubmed: 29917326
J Biophotonics. 2018 Nov;11(11):e201800008
pubmed: 29931742
FASEB J. 2019 Jan;33(1):1199-1208
pubmed: 30102569
Exp Eye Res. 2019 Apr;181:213-222
pubmed: 30771295
Cancer Cell. 2019 Mar 18;35(3):457-472.e5
pubmed: 30773340
Genes Chromosomes Cancer. 1997 May;19(1):22-8
pubmed: 9135991
Clin Exp Metastasis. 1997 Sep;15(5):509-18
pubmed: 9247253

Auteurs

Léo Piquet (L)

Faculté de médecine, Université Laval, Quebec City, QC G1V 0A6, Canada.
Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada.
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada.

Louise Dewit (L)

Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada.

Nathan Schoonjans (N)

Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada.
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada.

Martial Millet (M)

Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada.

Julie Bérubé (J)

Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada.

Peter R A Gerges (PRA)

Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.

François Bordeleau (F)

Faculté de médecine, Université Laval, Quebec City, QC G1V 0A6, Canada.
Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada.
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada.

Solange Landreville (S)

Faculté de médecine, Université Laval, Quebec City, QC G1V 0A6, Canada. Solange.Landreville@fmed.ulaval.ca.
Centre de recherche du CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada. Solange.Landreville@fmed.ulaval.ca.
Centre de recherche sur le cancer de l'Université Laval, Quebec City, QC G1R 3S3, Canada. Solange.Landreville@fmed.ulaval.ca.
Centre de recherche en organogénèse expérimentale de l'Université Laval/LOEX, Quebec City, QC G1J 1Z4, Canada. Solange.Landreville@fmed.ulaval.ca.

Classifications MeSH